NCT05770271Completed
The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis
A Novel Electrolyzed Water Spray Reduces the Itching Scores of Patients With Mild Senile Groin Eczema, Neurodermatitis and Psoriasis: A Clinical Study
Source: ClinicalTrials.gov · Last updated 25 Apr 2024
Brief summary (registry, in English)
The purpose of this study is to test whether spraying the itching of inflammation skin and groin patients by use of the novel electrolyzed water spray will produce improvement in the condition of itching.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 26 Feb 2023
- Start date
- 29 Jan 2023
- Primary completion date
- 20 Jul 2023
- Lead sponsor
- Dove Medical Press Ltd
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT05770271
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 29 Jan 2023 to the primary completion date, 20 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- people with cognitive disorders.
Other
- severe senile groin eczema, neurodermatitis and psoriasis.
- 80 years or older.
Who the study is looking for
- mild senile groin eczema, neurodermatitis and psoriasis.
Age in the registry: 35 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huinuode Biotechnology Co., Ltd. Coordinator of this site? Confirm its status | Qingdao | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.